Schroeder Theodore R
SEC insider (Form 3/4/5 filer). CIK 0001378690. Director at Phathom Pharmaceuticals, Inc. (PHAT) and 1 other issuer. 15 reported Form 4/5 transactions since Sep 2024; latest on May 19, 2026. Located in SAN DIEGO, CA.
Companies Schroeder Theodore R has filed insider reports for
- Phathom Pharmaceuticals, Inc. (PHAT): Director
- Cidara Therapeutics, Inc. (CDTX): Director
Schroeder Theodore R
CIK: 0001378690
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (15 total)
- May 19, 2026PHAT
Phathom Pharmaceuticals, Inc.
AwardDirect24.1K shares- - Jan 7, 2026CDTX
Cidara Therapeutics, Inc.
DispositionDirectStock Option (right to buy)
450 shares- - Jan 7, 2026CDTX
Cidara Therapeutics, Inc.
DispositionDirectStock Option (right to buy)
550 shares- - Jan 7, 2026CDTX
Cidara Therapeutics, Inc.
DispositionDirectStock Option (right to buy)
550 shares- - Jan 7, 2026CDTX
Cidara Therapeutics, Inc.
DispositionDirectStock Option (right to buy)
550 shares- - Jan 7, 2026CDTX
Cidara Therapeutics, Inc.
DispositionDirectStock Option (right to buy)
875 shares- - Jan 7, 2026CDTX
Cidara Therapeutics, Inc.
DispositionDirectStock Option (right to buy)
875 shares- - Jan 7, 2026CDTX
Cidara Therapeutics, Inc.
DispositionDirectStock Option (right to buy)
2.1K shares- - Jan 7, 2026CDTX
Cidara Therapeutics, Inc.
DispositionDirectStock Option (right to buy)
20.5K shares- - Jan 7, 2026CDTX
Cidara Therapeutics, Inc.
DispositionDirectStock Option (right to buy)
11.1K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| May 19, 2026 |  PHAT Phathom Pharmaceuticals, Inc. | Award | 24,122 | - | $0 | Direct |
| Jan 7, 2026 |  CDTX Cidara Therapeutics, Inc. | Disposition Stock Option (right to buy) | 450 | - | - | Direct |
| Jan 7, 2026 | CDTX Cidara Therapeutics, Inc. | Disposition Stock Option (right to buy) | 550 | - | - | Direct |
| Jan 7, 2026 | CDTX Cidara Therapeutics, Inc. | Disposition Stock Option (right to buy) | 550 | - | - | Direct |
| Jan 7, 2026 | CDTX Cidara Therapeutics, Inc. | Disposition Stock Option (right to buy) | 550 | - | - | Direct |
| Jan 7, 2026 | CDTX Cidara Therapeutics, Inc. | Disposition Stock Option (right to buy) | 875 | - | - | Direct |
| Jan 7, 2026 | CDTX Cidara Therapeutics, Inc. | Disposition Stock Option (right to buy) | 875 | - | - | Direct |
| Jan 7, 2026 | CDTX Cidara Therapeutics, Inc. | Disposition Stock Option (right to buy) | 2,125 | - | - | Direct |
| Jan 7, 2026 | CDTX Cidara Therapeutics, Inc. | Disposition Stock Option (right to buy) | 20,500 | - | - | Direct |
| Jan 7, 2026 | CDTX Cidara Therapeutics, Inc. | Disposition Stock Option (right to buy) | 11,100 | - | - | Direct |
1-10 of 15 transactions